AU2004287440A1 - Dialysates and methods and systems related thereto - Google Patents

Dialysates and methods and systems related thereto Download PDF

Info

Publication number
AU2004287440A1
AU2004287440A1 AU2004287440A AU2004287440A AU2004287440A1 AU 2004287440 A1 AU2004287440 A1 AU 2004287440A1 AU 2004287440 A AU2004287440 A AU 2004287440A AU 2004287440 A AU2004287440 A AU 2004287440A AU 2004287440 A1 AU2004287440 A1 AU 2004287440A1
Authority
AU
Australia
Prior art keywords
pyrophosphate
type compound
dialysate
groups
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004287440A
Other languages
English (en)
Inventor
Koba Lomashvili
W. Charles O'neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of AU2004287440A1 publication Critical patent/AU2004287440A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2004287440A 2003-10-28 2004-10-27 Dialysates and methods and systems related thereto Abandoned AU2004287440A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51517403P 2003-10-28 2003-10-28
US60/515,174 2003-10-28
PCT/US2004/035541 WO2005044189A2 (en) 2003-10-28 2004-10-27 Dialysates and methods and systems related thereto

Publications (1)

Publication Number Publication Date
AU2004287440A1 true AU2004287440A1 (en) 2005-05-19

Family

ID=34572815

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004287440A Abandoned AU2004287440A1 (en) 2003-10-28 2004-10-27 Dialysates and methods and systems related thereto

Country Status (9)

Country Link
US (1) US20070148258A1 (cg-RX-API-DMAC7.html)
EP (1) EP1682077A4 (cg-RX-API-DMAC7.html)
JP (1) JP4838139B2 (cg-RX-API-DMAC7.html)
KR (1) KR101249707B1 (cg-RX-API-DMAC7.html)
CN (2) CN103054901A (cg-RX-API-DMAC7.html)
AU (1) AU2004287440A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416088A (cg-RX-API-DMAC7.html)
CA (1) CA2544235C (cg-RX-API-DMAC7.html)
WO (1) WO2005044189A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
EP2206504A4 (en) 2007-10-05 2014-02-12 Univ Chiba Nat Univ Corp STABLE IONIC BICARBONATE MEDICINES SOLUTION
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
JP5258448B2 (ja) * 2008-08-12 2013-08-07 扶桑薬品工業株式会社 透析用製剤
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Vantive Health Gmbh Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
EP2560663B1 (en) * 2010-04-23 2016-06-22 Baxter International Inc. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
CN102517635B (zh) * 2012-01-12 2014-12-24 中国科学院新疆理化技术研究所 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法
EP2862583A1 (en) * 2013-10-17 2015-04-22 Gambro Lundia AB Perm selective membrane for treating vascular calcification in chronic hemodialysis patients
DE102015007842A1 (de) * 2015-06-18 2016-12-22 Fresenius Medical Care Deutschland Gmbh Dialyselösung
US20200009163A1 (en) * 2017-03-06 2020-01-09 University Of Houston System Polyphosphates as inhibitors of calcium crystallization
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
MX2021003653A (es) 2018-10-11 2021-06-23 Sanifit Therapeutics S A Inositol fosfatos para el tratamiento de calcificacion ectopica.
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN118416279B (zh) * 2024-04-23 2025-09-02 大连医科大学附属第二医院 一种预防血管钙化的动静脉内瘘外用敷料及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9903442A3 (en) * 1996-02-08 2001-11-28 Warner Lambert Co Anticalculus dentifrice containing highly soluble pyrophosphate
AU736053B2 (en) * 1996-12-31 2001-07-26 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
US6689275B1 (en) * 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
US6779468B1 (en) * 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
JP2002249433A (ja) * 2000-12-19 2002-09-06 Sumitomo Pharmaceut Co Ltd 血管石灰化抑制剤
US20040241249A1 (en) 2001-06-18 2004-12-02 Tina Sampalis Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport
US6524788B1 (en) * 2001-11-02 2003-02-25 Thomas L. Cantor Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion

Also Published As

Publication number Publication date
EP1682077A2 (en) 2006-07-26
EP1682077A4 (en) 2009-07-01
CA2544235C (en) 2013-12-10
WO2005044189A2 (en) 2005-05-19
JP4838139B2 (ja) 2011-12-14
JP2007523056A (ja) 2007-08-16
US20070148258A1 (en) 2007-06-28
CN103054901A (zh) 2013-04-24
CN101094681A (zh) 2007-12-26
BRPI0416088A (pt) 2007-01-02
KR101249707B1 (ko) 2013-04-05
KR20070014110A (ko) 2007-01-31
CA2544235A1 (en) 2005-05-19
WO2005044189A3 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
CA2544235C (en) Dialysates and methods and systems related thereto
JP2007523056A5 (cg-RX-API-DMAC7.html)
US20220257767A1 (en) Ionic liquids for drug delivery
EP0643969B1 (en) Dialysis solution for extracorporeal hemodialysis
JP5919597B2 (ja) デオキシコール酸およびその塩類の製剤
US9511053B2 (en) Nitric oxide scavengers
CA3172535A1 (en) Cyclophilin inhibitors and uses thereof
EA018245B1 (ru) Органические соединения трехвалентного железа фармацевтического качества, их применение и способы их получения
JPS6154006B2 (cg-RX-API-DMAC7.html)
IL295014A (en) Preparations for the treatment of angiolipoma
JP2022521119A (ja) 組織の灌流の増加における使用のためのイノシトールリン酸化合物
JP6889504B2 (ja) 透析装置、アクセプター薬剤、ドナー薬剤、リンス液およびリンス液としての使用方法
MXPA06004730A (en) Dialysates and methods and systems related thereto
JP6219430B2 (ja) デオキシコール酸およびその塩類の製剤
TW200306811A (en) Medicinal compositions for inhibiting tryptase
JP5747263B2 (ja) 神経細胞死抑制剤
KR20150014910A (ko) 허혈-재관류계 질환의 치료 화합물
DK154609B (da) Fremgangsmaade til mindskelse eller fjernelse af uoenskede bivirkninger hos cytostatisk aktive alkylaner
JPH0737388B2 (ja) 腎機能改善剤
RU2169570C1 (ru) Способ лечения перитонита
JP6594486B2 (ja) デオキシコール酸およびその塩類の製剤
JP6356329B2 (ja) デオキシコール酸およびその塩類の製剤
SU1588420A1 (ru) Способ профилактики отторжени аллотрансплантированной почки
WO2025141294A1 (en) Novel hydrogen sulfide releasing compounds
CH Sulphamerazine: a New Sulphonamide

Legal Events

Date Code Title Description
MK3 Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination